Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Exp Neurol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    September 2017
  1. KUHN J, Haumesser JK, Beck MH, Altschuler J, et al
    Differential effects of levodopa and apomorphine on neuronal population oscillations in the cortico-basal ganglia loop circuit in vivo in experimental parkinsonism.
    Exp Neurol. 2017 Sep 8. pii: S0014-4886(17)30235.
    PubMed     Text format     Abstract available


    August 2017
  2. JAMES SURMEIER D, Halliday GM, Simuni T
    Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
    Exp Neurol. 2017 Aug 2. pii: S0014-4886(17)30206.
    PubMed     Text format     Abstract available


    July 2017
  3. WEST AB
    Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease.
    Exp Neurol. 2017 Jul 29. pii: S0014-4886(17)30203.
    PubMed     Text format     Abstract available


  4. KO WKD, Bezard E
    Experimental animal models of Parkinson's disease: A transition from assessing symptomatology to alpha-synuclein targeted disease modification.
    Exp Neurol. 2017 Jul 29. pii: S0014-4886(17)30202.
    PubMed     Text format     Abstract available


  5. FISCHER P, Pogosyan A, Cheeran B, Green AL, et al
    Subthalamic nucleus beta and gamma activity is modulated depending on the level of imagined grip force.
    Exp Neurol. 2017;293:53-61.
    PubMed     Text format     Abstract available


    June 2017
  6. CROTTY GF, Ascherio A, Schwarzschild MA
    Targeting urate to reduce oxidative stress in Parkinson disease.
    Exp Neurol. 2017 Jun 13. pii: S0014-4886(17)30157.
    PubMed     Text format     Abstract available


  7. MEADOWS SM, Chambers NE, Conti MM, Bossert SC, et al
    Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia.
    Exp Neurol. 2017;292:168-178.
    PubMed     Text format     Abstract available


    May 2017
  8. MOREIRA S, Fonseca I, Nunes MJ, Rosa A, et al
    Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.
    Exp Neurol. 2017 May 25. pii: S0014-4886(17)30126.
    PubMed     Text format     Abstract available


  9. LAZARO DF, Pavlou MAS, Outeiro TF
    Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease.
    Exp Neurol. 2017 May 16. pii: S0014-4886(17)30124.
    PubMed     Text format     Abstract available


    April 2017
  10. SCOTT L, Dawson VL, Dawson TM
    Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes.
    Exp Neurol. 2017 Apr 23. pii: S0014-4886(17)30102.
    PubMed     Text format     Abstract available


  11. ALAM M, Rumpel R, Jin X, von Wrangel C, et al
    Altered somatosensory cortex neuronal activity in a rat model of Parkinson's disease and levodopa-induced dyskinesias.
    Exp Neurol. 2017 Apr 23. pii: S0014-4886(17)30101.
    PubMed     Text format     Abstract available


  12. OLIVEIRA LM, Tuppy M, Moreira TS, Takakura AC, et al
    Role of the locus coeruleus catecholaminergic neurons in the chemosensory control of breathing in a Parkinson's disease model.
    Exp Neurol. 2017;293:172-180.
    PubMed     Text format     Abstract available


    March 2017
  13. BIMPISIDIS Z, M Oberg C, Maslava N, Cenci MA, et al
    Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease.
    Exp Neurol. 2017 Mar 8. pii: S0014-4886(17)30066.
    PubMed     Text format     Abstract available


    February 2017
  14. MONNOT C, Zhang X, Nikkhou-Aski S, Damberg P, et al
    Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism.
    Exp Neurol. 2017 Feb 18. pii: S0014-4886(17)30048.
    PubMed     Text format     Abstract available


    January 2017
  15. FRAU R, Savoia P, Fanni S, Fiorentini C, et al
    The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
    Exp Neurol. 2017;291:1-7.
    PubMed     Text format     Abstract available


  16. HAO F, Yang C, Chen SS, Wang YY, et al
    Long-Term Protective Effects of AAV9-Mesencephalic Astrocyte-Derived Neurotrophic Factor Gene Transfer in Parkinsonian Rats.
    Exp Neurol. 2017 Jan 25. pii: S0014-4886(17)30016.
    PubMed     Text format     Abstract available


  17. FJODOROVA M, Torres EM, Dunnett SB
    Transplantation site influences the phenotypic differentiation of dopamine neurons in ventral mesencephalic grafts in Parkinsonian rats.
    Exp Neurol. 2017 Jan 25. pii: S0014-4886(17)30019.
    PubMed     Text format     Abstract available


    December 2016
  18. BENTEA E, Van Liefferinge J, Verbruggen L, Martens K, et al
    Zonisamide attenuates lactacystin-induced parkinsonism in mice without affecting system xc.
    Exp Neurol. 2016 Dec 23. pii: S0014-4886(16)30418.
    PubMed     Text format     Abstract available


    October 2016
  19. BECK MH, Haumesser JK, Kuhn J, Altschuler J, et al
    Short- and long-term dopamine depletion causes enhanced beta oscillations in the cortico-basal ganglia loop of parkinsonian rats.
    Exp Neurol. 2016;286:124-136.
    PubMed     Text format     Abstract available


    September 2016
  20. MULAS G, Espa E, Fenu S, Spiga S, et al
    Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.
    Exp Neurol. 2016 Sep 30. pii: S0014-4886(16)30299.
    PubMed     Text format     Abstract available


  21. WU Q, Yang X, Zhang Y, Zhang L, et al
    Chronic mild stress accelerates the progression of Parkinson's disease in A53T alpha-synuclein transgenic mice.
    Exp Neurol. 2016;285.
    PubMed     Text format     Abstract available


    July 2016
  22. GEE LE, Walling I, Ramirez-Zamora A, Shin DS, et al
    Subthalamic deep brain stimulation alters neuronal firing in canonical pain nuclei in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
    Exp Neurol. 2016;283.
    PubMed     Text format     Abstract available


    June 2016
  23. CONCANNON RM, Okine BN, Finn DP, Dowd E, et al
    Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.
    Exp Neurol. 2016 Jun 14. pii: S0014-4886(16)30179.
    PubMed     Text format     Abstract available


    May 2016
  24. LI M, Zhou M, Wen P, Wang Q, et al
    The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
    Exp Neurol. 2016 May 6. pii: S0014-4886(16)30122.
    PubMed     Text format     Abstract available


    April 2016
  25. SGROI S, Capper-Loup C, Paganetti P, Kaelin-Lang A, et al
    Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats.
    Exp Neurol. 2016 Apr 9. pii: S0014-4886(16)30066.
    PubMed     Text format     Abstract available


    March 2016
  26. MURALIDHARAN A, Jensen AL, Connolly A, Hendrix CM, et al
    Physiological changes in the pallidum in a progressive model of Parkinson's disease: Are oscillations enough?
    Exp Neurol. 2016 Mar 2. pii: S0014-4886(16)30046.
    PubMed     Text format     Abstract available


    February 2016
  27. LELOS MJ, Morgan RJ, Kelly CM, Torres EM, et al
    Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.
    Exp Neurol. 2016 Feb 3. pii: S0014-4886(16)30025.
    PubMed     Text format     Abstract available


    December 2015
  28. ANZAK A, Tan H, Pogosyan A, Khan S, et al
    Subcortical evoked activity and motor enhancement in Parkinson's disease.
    Exp Neurol. 2015 Dec 11. pii: S0014-4886(15)30131.
    PubMed     Text format     Abstract available


    November 2015
  29. BENSAID M, Michel PP, Clark SD, Hirsch EC, et al
    Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
    Exp Neurol. 2015 Nov 10. pii: S0014-4886(15)30118.
    PubMed     Text format     Abstract available


  30. SASAKI T, Liu K, Agari T, Yasuhara T, et al
    Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.
    Exp Neurol. 2015 Nov 7. pii: S0014-4886(15)30117.
    PubMed     Text format     Abstract available


    October 2015
  31. HUANG Q, Du X, He X, Yu Q, et al
    JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
    Exp Neurol. 2015 Oct 26. pii: S0014-4886(15)30111.
    PubMed     Text format     Abstract available


  32. MARTIN CA, Myers KM, Chen A, Martin NT, et al
    Ziram, a pesticide associated with increased risk for Parkinson's disease, differentially affects the presynaptic function of aminergic and glutamatergic nerve terminals at the Drosophila neuromuscular junction.
    Exp Neurol. 2015 Oct 3. pii: S0014-4886(15)30099.
    PubMed     Text format     Abstract available


    August 2015
  33. MOUNSEY RB, Mustafa S, Robinson L, Ross RA, et al
    Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Exp Neurol. 2015 Aug 2. pii: S0014-4886(15)30058.
    PubMed     Text format     Abstract available


    May 2015
  34. YANG X, Zhao H, Shi H, Wang X, et al
    Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Exp Neurol. 2015 May 19. pii: S0014-4886(15)00154.
    PubMed     Text format     Abstract available


  35. SMITH RC, O'Bryan LM, Mitchell PJ, Leung D, et al
    Increased brain bio-distribution and chemical stability and decreased immunogenicity of an engineered variant of GDNF.
    Exp Neurol. 2015;267:165-76.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: